We recently published 10 Stocks Hit by Painful Plunge. Novo Nordisk A/S (NYSE:NVO) is one of the best-performing stocks on ...

A Lilly study showed Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with ...

That pundit was HSBC's Rajesh Kumar, who downgraded his recommendation on Novo Nordisk that morning. Image source: . Kumar ...

Yesterday, we reported that Novo Nordisk (NYSE: NVO) stock crashed over 20% in premarket trading yesterday. The main culprit is the reduced sales forecast for the company’s flagship obesity drug ...

Despite a steep 65% drop from its all-time high of 145.99 a share in the prior 12 months, Novo Nordisk remains one of the most operationally sound businesses on the planet. As an investor, you are ...

In the latest trading session, Novo Nordisk (NVO) closed at $47.00, marking a -6.06% move from the previous day. This change lagged the S&P 500's 0.37% loss on the day. Elsewhere, the Dow saw a ...

U.S.-listed shares of Arm Holdings fell sharply in premarket trading Thursday, a day after the chip and software design firm ...

Stock futures climbed on Thursday (July 31) after strong quarterly results from tech heavyweights Microsoft and Meta ...

July's jobs report reveals mixed signals. Discover key sectors with growth momentum and risks in labor trends to ...

The unusually intense rainfall over these weeks has pushed July close to ranking among the ten wettest months on record since 1874, writes DR. During the month coming to an end today, the country has ...

Explore this week's standout equity moves including Next's guidance upgrades, Novo Nordisk's warning and Fresnillo's ...

A rally in stocks sputtered ahead of President Donald Trump’s tariff deadline, with the White House demanding drugmakers to ...